Showing results (301-310 of 536) with videos related to
Sort By:
Pageof 54
Clinical and Experimental Nephrology|September 30, 2006
Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL studyKiyoshi Kurokawa, Juliana C N Chan, Mark E Cooper, et al.Diabetes|April 28, 2011
Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathyMichal Herman-Edelstein, Merlin C Thomas, Vicki Thallas-Bonke, et al.Journal of the American Society of Nephrology : JASN|February 22, 2002
Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2)27 ratsSally A Mifsud, Sandford L Skinner, Mark E Cooper, et al.Kidney International|August 26, 2004
Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetesMerlin C Thomas, Con Tsalamandris, Richard MacIsaac, et al.Diabetes Care|September 13, 2013
Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunctionPer-Henrik Groop, Mark E Cooper, Vlado Perkovic, et al.Gastroenterology|October 31, 2002
Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liverGeorgina Paizis, Mark E Cooper, Josefa M Schembri, et al.Journal of Hypertension|February 18, 2005
Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetesKarin A M Jandeleit-Dahm, Christos Tikellis, Christopher M Reid, et al.Current Drug Targets|July 24, 2015
Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?Karly C Sourris, Henry Yao, George Jerums, et al.The Journal of Pharmacology and Experimental Therapeutics|June 24, 2004
The role of advanced glycation in reduced organic cation transport associated with experimental diabetesMerlin C Thomas, Christos Tikellis, Phillip Kantharidis, et al.Journal of the American Society of Nephrology : JASN|September 20, 2001
Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathyDarren J Kelly, Richard E Gilbert, Alison J Cox, et al.Pageof 54